• Cyclosporin A: From Mechanism to Translation

  2026-08-20

  Cyclosporin A is more than a calcineurin inhibitor. Its cyclophilin-dependent biology, membrane behavior, and variant-specific mitochondrial activity provide a practical framework for designing more predictive immunology and mitochondrial studies.

• KN-62 Workflows for CaMKII Signaling

  2026-08-19

  KN-62 enables controlled interrogation of CaMKII-dependent calcium signaling in secretion, metabolism, and cell-cycle assays. This guide pairs practical dosing and troubleshooting with an orthogonal channel-pharmacology framework drawn from neuronal electrophysiology.

• Sulfo-Cy3 NHS Ester in Vascular Translation

  2026-08-19

  Translational vascular research increasingly depends on methods that preserve biomolecular behavior while making complex mechanisms visible. This article examines how Sulfo-Cy3 NHS ester, a hydrophilic fluorescent dye for amino-group labeling, can support mechanistic studies of the AIBP–LRP2–HDL–miR-223–CXCR4 axis and help researchers build more reproducible workflows from conjugation chemistry to vascular phenotyping.

• N-Formimidoyl Thienamycin: Comparative Antibacterial Evidenc

  2026-08-18

  This 1982 study evaluated N-formimidoyl thienamycin (MK0787) against a broad panel of resistant clinical isolates and compared it with several contemporary β-lactam antibiotics. Its strongest contributions were the demonstration of activity against Pseudomonas aeruginosa and Acinetobacter spp., bactericidal effects against gram-negative isolates, and apparent independence from β-lactamase production.

• MEK1/2, c-Myc, and TERT in Human Stem Cells

  2026-08-18

  This preprint identifies a regulatory connection in which MEK1/2–ERK signaling and c-Myc:MAX cooperate to maintain TERT transcription in human embryonic stem cells by limiting PRC2-associated repression. Its findings link kinase signaling, transcription-factor occupancy, and opposing H3K27 methylation and acetylation states at the TERT promoter, offering a mechanistic framework for studying telomere regulation in normal pluripotent cells.

• Caspofungin Workflows for Resistant Candida

  2026-08-17

  Build resistance-aware Candida assays around Caspofungin, a lipopeptide antifungal drug that targets β-(1,3)-D-glucan production. This guide connects susceptibility testing with delayed-treatment models, comparator design, and practical troubleshooting for translational antifungal therapeutics research.

• Ivermectin: Mechanism, Evidence, and Research Limits

  2026-08-17

  Ivermectin is a broad-spectrum anti-parasitic agent used in approved therapies for selected nematode and ectoparasite infections. This article separates established pharmacology and product specifications from unsupported extensions, including claims about cancer or COVID-19.

• Doxycycline for Hydrogel Mechanobiology Research

  2026-08-16

  Learn how to use Doxycycline as a controlled perturbation in 3D hydrogel assays that connect matrix remodeling, cell motion, and differentiation. This workflow also separates antimicrobial, antiproliferative, and metalloproteinase-related effects from genuine nuclear mechanotransduction signals.

• Sex Differences in Angiotensin II Hypertension

  2026-08-15

  Xue, Pamidimukkala, and Hay used telemetry in conscious mice to show that chronic angiotensin II produces substantially greater hypertension in males than females. Gonadectomy, baroreflex testing, and ganglionic blockade further implicated sex hormones, altered autonomic regulation, and sympathetic activity in the divergent blood-pressure responses.

• Galectin-1, FIP200, and Autophagy in Hepatic Steatosis

  2026-08-14

  The reference study identifies galectin-1 as an upstream driver of hepatic steatosis and insulin resistance through direct interference with the autophagy scaffold FIP200. By combining mouse models, proteomics, biochemical binding analysis, structural mapping, and interaction-disrupting mutations, the work defines the Gal-1–FIP200 axis as a mechanistic target in metabolic liver disease research.

• Cinoxacin: In Vitro Antibacterial Study Findings

  2026-08-14

  The 1975 study by Lumish and Norden established a systematic in vitro profile for Cinoxacin, combining susceptibility testing, disk diffusion, bactericidal assays, and serial-passage resistance experiments. Its findings defined strong activity against many aerobic gram-negative bacilli while identifying limited activity against Pseudomonas aeruginosa and Gram-positive isolates, creating a practical foundation for urinary tract infection research and later quinolone comparisons.

• Ciprofloxacin, Zinc, and RSL3-Induced Ferroptosis

  2026-08-13

  The reference study identifies a context-dependent role for ciprofloxacin in ferroptosis: although the antibiotic can protect cells from erastin-induced ferroptosis, it potentiates RSL3-triggered death by promoting mitochondrial Zn2+ accumulation. Its mechanistic model connects topoisomerase 2β inhibition, mitochondrial DNA stress, the STING1–CAV2 pathway, SLC25A25-dependent zinc transport, and mitochondrial reactive oxygen species, providing a framework for interpreting combination cytotoxicity experiments.

• CA-074 Me: Reading Lysosomal Death Signals

  2026-08-13

  CA-074 Me is a cell-permeable cathepsin B inhibitor for dissecting lysosomal membrane permeabilization, necroptosis, and apoptosis. This article presents a causal, time-resolved assay framework that separates lysosomal rupture from downstream protease-dependent cell death.

• GS967 for Cardiac Late Sodium Current Research

  2026-08-12

  GS967 enables targeted investigation of pathological late sodium influx across ventricular myocyte, isolated-heart, aging, and ischemia models. Its concentration- and voltage-dependent activity supports workflows that connect sodium current inhibition with repolarization, calcium handling, contractile relaxation, and arrhythmia outcomes.

• VX-661: Reading the Biology of CFTR Rescue

  2026-08-12

  VX-661 is a F508del CFTR corrector that links protein-folding rescue to functional channel recovery. This guide shows how to separate trafficking, proteostasis, and gating effects when designing cystic fibrosis research assays.

8424 records 2/562 page Previous Next 12345 下5页 Last page